Medical technology giant Medtronic plcMDT recently completed the acquisition of HeartWare International, Inc. HTWR - a global medical device manufacturer dedicated to serve patients with advanced ...

Heartware International (HTWR) is watching its shares absolutely skyrocket in Monday’s session despite the huge market downturn from the Brexit. This surge is the result of Medtronic PLC (MDT) moving ...

HeartWare International Inc (NASDAQ: HTWR), a developer of medical devices, confirmed on Wednesday it has received notice from Engaged Capital, an activist hedge fund and shareholder, which nominated ...

The US Food and Drug Administration (FDA) is notifying physicians of a Class I recall of unimplanted HeartWare ventricular assist device (VAD) implant kits, initiated voluntarily by the company in ...

The FDA's Circulatory System Devices panel voted 9-2 on Wednesday to recommend approval of the HeartWare Ventricular Assist System as a bridge to heart transplantation for patients with end-stage ...

The FDA said today that it had granted approval to the HeartWare Ventricular Assist System for use in heart failure patients waiting for a transplant. Approval of the device had been expected after ...

Both the agency and its panel of advisors had been concerned about an annual 9.2% rate of pump-related thrombus observed in the nonrandomized ADVANCE trial, which compared the HeartWare device ...

Shares of HeartWare International jumped 14 percent before the market opened Thursday, after a heart pump made by the company received a positive recommendation from a regulatory panel. The Food and ...

FRAMINGHAM, MA — The US Food and Drug Administration issued a formal warning to the makers of a recently approved ventricular assist device (VAD) system (HeartWare, Framingham, MA) for failing to take ...

Medtronic PLCMDT-1.42%decrease; down pointing triangle said Monday that it agreed to acquire HeartWare International Inc. for $1.1 billion, adding more heart-treatment products to the medical-device ...

On 22 March 2006, a 48 year old male patient suffering NYHA Class IV Heart Failure became the first recipient of HeartWare's HVAD mechanical circulatory assist device. The implant was conducted at the ...

FRAMINGHAM, Mass. and SYDNEY, Australia, April 18 HeartWare Limited (ASX: HTW) today announced that it is moving to an expanded,upgraded manufacturing facility in Miami Lakes, FL, USA. The new ...